Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
An innovative treatment for Gaucher disease has produced promising results in mice, giving hope to patients after decades of...
A new algorithm may greatly speed up the process of engineering therapeutic antibodies
In a major step toward greener industry, Weizmann Institute scientists create a computational method for generating enzymes with unprecedented...
Forget crystals. AI gives Weizmann’s algorithms the means to design biomolecules with a huge range of valuable functions
New proteins, created through long-distance collaboration, might lead to the reversal of antibiotic resistance in certain bacteria
Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process
Proto-enzymes designed in the lab bound strongly to RNA and DNA, suggesting a surprising origin for these proteins
The Institute will fund innovative research on compounds that hold promise for becoming therapies for a range of human diseases and...
A computational method for designing dramatically more efficient versions of enzymes may lead to new avenues of drug design and new treatments...
Dr. Sarel Fleishman is the recipient of a Morris L. Levinson Prize in Biology awarded by the Scientific Council